Anthocyanin-rich extract from Aronia meloncarpa E. induces a cell cycle block in colon cancer but not normal colonic cells

被引:143
作者
Malik, M
Zhao, CW
Schoene, N
Guisti, MM
Moyer, MP
Magnuson, BA [1 ]
机构
[1] Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA
[2] USDA, Beltsville Human Nutr Res Ctr, Beltsville, MD 20705 USA
[3] INCELL Corp, LLC, San Antonio, TX USA
来源
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL | 2003年 / 46卷 / 02期
关键词
D O I
10.1207/S15327914NC4602_12
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Anthocyanin-rich extracts, potent antioxidants and commercially available food coloring agents, have been reported to inhibit growth of various cancer cell lines. We investigated the effect of semipurified anthocyanin-rich extract from fruits of Aronia meloncarpa, on normal colon and colon cancer cell lines. A 24-h exposure to 50 mug monomeric anthocyanin/ml of Aronia extract resulted in 60% growth inhibition of human HT-29 colon cancer cells. The treated cells showed a blockage at G1/G0 and G2/M phases of the cell cycle. The cell cycle arrest coincided with an increased expression of the p21(WAF1) and p27(KIP1) genes and decreased expression of cyclin A and B genes. Prolonged exposure to the extract resulted in no further change in the cell number indicating a cytostatic inhibition of cell growth. NCM460 normal colon cells demonstrated < 10% growth inhibition at the highest concentration of 50 mug/ml extract. A 35% decrease in the cyclooxygenase-2 gene expression was observed within 24 h of exposure of HT-29 cells but did not translate into decreased protein levels or protein activity. These results support the need for further research to identify the specific component(s) in this extract that suppress cancer cell growth and the genes affected by these natural compounds.
引用
收藏
页码:186 / 196
页数:11
相关论文
共 42 条
[1]  
Battu S, 1998, ANTICANCER RES, V18, P2397
[2]  
Borissova P, 1994, Acta Physiol Pharmacol Bulg, V20, P25
[3]  
Cao GH, 1999, CLIN CHEM, V45, P574
[4]   p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells [J].
Cayrol, C ;
Knibiehler, M ;
Ducommun, B .
ONCOGENE, 1998, 16 (03) :311-320
[5]   p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells [J].
Choi, YH ;
Lee, WH ;
Park, KY ;
Zhang, LJ .
JAPANESE JOURNAL OF CANCER RESEARCH, 2000, 91 (02) :164-173
[6]   Separation and purification of anthocyanins by high-speed countercurrent chromatography and screening for antioxidant activity [J].
Degenhardt, A ;
Knapp, H ;
Winterhalter, P .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2000, 48 (02) :338-343
[7]   Nonsteroidal antiinflammatory drugs, eicosanoids, and colorectal cancer prevention [J].
DuBois, RN ;
Giardiello, FM ;
Smalley, WE .
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 1996, 25 (04) :773-+
[8]   UP-REGULATION OF CYCLOOXYGENASE-2 GENE-EXPRESSION IN HUMAN COLORECTAL ADENOMAS AND ADENOCARCINOMAS [J].
EBERHART, CE ;
COFFEY, RJ ;
RADHIKA, A ;
GIARDIELLO, FM ;
FERRENBACH, S ;
DUBOIS, RN .
GASTROENTEROLOGY, 1994, 107 (04) :1183-1188
[9]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[10]   Effects of genistein on cell proliferation and cell cycle arrest in nonneoplastic human mammary epithelial cells:: involvement of Cdc2, p21waf/cip1, p27kip1, and Cdc25C expression [J].
Frey, RS ;
Li, JY ;
Singletary, KW .
BIOCHEMICAL PHARMACOLOGY, 2001, 61 (08) :979-989